BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38691204)

  • 1. Predicting response of hepatoblastoma primary lesions to neoadjuvant chemotherapy through contrast-enhanced computed tomography radiomics.
    Yang Y; Wang H; Si J; Zhang L; Ding H; Wang F; He L; Chen X
    J Cancer Res Clin Oncol; 2024 Apr; 150(5):223. PubMed ID: 38691204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computed tomography imaging phenotypes of hepatoblastoma identified from radiomics signatures are associated with the efficacy of neoadjuvant chemotherapy.
    Chen Y; Froelich MF; Tharmaseelan H; Jiang H; Wang Y; Li H; Tao M; Gao Y; Wang J; Liu J; Schoenberg SO; Feng S; Weis M
    Pediatr Radiol; 2024 Jan; 54(1):58-67. PubMed ID: 37982901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
    World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced computed tomography radiomics in predicting primary site response to neoadjuvant chemotherapy in high-risk neuroblastoma.
    Wang H; Qin J; Chen X; Zhang T; Zhang L; Ding H; Pan Z; He L
    Abdom Radiol (NY); 2023 Mar; 48(3):976-986. PubMed ID: 36571609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Computed Tomography-Based Radiomics Signature to Predict Response to Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.
    Wang W; Peng Y; Feng X; Zhao Y; Seeruttun SR; Zhang J; Cheng Z; Li Y; Liu Z; Zhou Z
    JAMA Netw Open; 2021 Aug; 4(8):e2121143. PubMed ID: 34410397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced CT features of hepatoblastoma: Can we predict histopathology?
    Baheti AD; Luana Stanescu A; Li N; Chapman T
    Clin Imaging; 2017; 44():33-37. PubMed ID: 28399447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful resection for advanced hepatoblastoma, combined with perioperative chemotherapy.
    Kusano T; Aoki H; Kinjo T; Miyazato H; Shimoji H; Isa T; Muto Y
    J Hepatobiliary Pancreat Surg; 2000; 7(4):410-6. PubMed ID: 11180863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced gastric cancer: CT radiomics prediction and early detection of downstaging with neoadjuvant chemotherapy.
    Xu Q; Sun Z; Li X; Ye C; Zhou C; Zhang L; Lu G
    Eur Radiol; 2021 Nov; 31(11):8765-8774. PubMed ID: 33909133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging analysis of hepatoblastoma resectability across neoadjuvant chemotherapy.
    Murphy AJ; Ayers GD; Hilmes MA; Mukherjee K; Wilson KJ; Allen WM; Fernandez-Pineda I; Shinall MC; Zhao Z; Furman WL; McCarville MB; Davidoff AM; Lovvorn HN
    J Pediatr Surg; 2013 Jun; 48(6):1239-48. PubMed ID: 23845613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.
    O'Neill AF; Towbin AJ; Krailo MD; Xia C; Gao Y; McCarville MB; Meyers RL; McGahren ED; Tiao GM; Dunn SP; Langham MR; Weldon CB; Finegold MJ; Ranganathan S; Furman WL; Malogolowkin M; Rodriguez-Galindo C; Katzenstein HM
    J Clin Oncol; 2017 Oct; 35(30):3465-3473. PubMed ID: 28892430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer.
    Sun KY; Hu HT; Chen SL; Ye JN; Li GH; Chen LD; Peng JJ; Feng ST; Yuan YJ; Hou X; Wu H; Li X; Wu TF; Wang W; Xu JB
    BMC Cancer; 2020 May; 20(1):468. PubMed ID: 32450841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapy.
    Nguyen R; McCarville MB; Sykes A; Mao S; Wu J; Langham MR; Furman WL
    Int J Clin Oncol; 2018 Oct; 23(5):900-907. PubMed ID: 29744604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Delta-radiomics model for preoperative evaluation of Neoadjuvant chemotherapy response in high-grade osteosarcoma.
    Lin P; Yang PF; Chen S; Shao YY; Xu L; Wu Y; Teng W; Zhou XZ; Li BH; Luo C; Xu LM; Huang M; Niu TY; Ye ZM
    Cancer Imaging; 2020 Jan; 20(1):7. PubMed ID: 31937372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep learning-based radiomics predicts response to chemotherapy in colorectal liver metastases.
    Wei J; Cheng J; Gu D; Chai F; Hong N; Wang Y; Tian J
    Med Phys; 2021 Jan; 48(1):513-522. PubMed ID: 33119899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical Resection for Hepatoblastoma-Updated Survival Outcomes.
    Sunil BJ; Palaniappan R; Venkitaraman B; Ranganathan R
    J Gastrointest Cancer; 2018 Dec; 49(4):493-496. PubMed ID: 28963691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma.
    Venkatramani R; Stein JE; Sapra A; Genyk Y; Jhaveri V; Malogolowkin M; Mascarenhas L
    Br J Surg; 2015 Jan; 102(1):108-13. PubMed ID: 25349947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics-based model for predicting pathological complete response to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    Choi SJ; Park KJ; Heo C; Park BW; Kim M; Kim JK
    Clin Radiol; 2021 Aug; 76(8):627.e13-627.e21. PubMed ID: 33762138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy.
    Tang S; Ou J; Liu J; Wu YP; Wu CQ; Chen TW; Zhang XM; Li R; Tang MJ; Yang LQ; Tan BG; Lu FL; Hu J
    Cancer Imaging; 2021 May; 21(1):38. PubMed ID: 34039403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment Contrast-Enhanced Computed Tomography Radiomics for Prediction of Pathological Regression Following Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer: A Preliminary Multicenter Study.
    Xie K; Cui Y; Zhang D; He W; He Y; Gao D; Zhang Z; Dong X; Yang G; Dai Y; Li Z
    Front Oncol; 2021; 11():770758. PubMed ID: 35070974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.